Is the new Wilson LIC, WAM Strategic Value (ASX:WAR) a buy?
Whilst WAM Capital has proven form using the underlying investment strategies planned for this new LIC, there are a few reasons why I would be cautious about jumping in. The performance fee is high, opportunities for this overall strategy have dried up somewhat compared to last year, and then there are the usual potential issues of buying LICs at IPO.
Continue reading “WHICH LICs WILL WAM GO TO WAR ON? WAM STRATEGIC VALUE REVIEW (ASX:WAR)”
This is a guest post that I thought would be of interest to my readers. It is in the spirit of Melbourne Cup Day, so I will be tempted soon in having my own punt on a LIC trifecta in the comments section at the end (feel free to do the same). Please read below to find out more about the author. (Note I have no affiliation with the below author / business).
Continue reading “Guest Post – The ‘Melbourne Cup of LICs’: Our form guide and three favourites”
Pressure has been mounting on many ASX LICs this year to address issues of sub-par performance and widening discounts to NTA. In some cases this has led to corporate activity in the sector that has subsequently seen strong returns in the shorter term for such LICs.
Continue reading “5 FACTORS FOR PROFITING FROM ASX LIC TAKEOVERS AND WIND UPS”
I often mention to other investors that looking for opportunities in the ASX Listed Investment Company (LIC) sector has been a significant part of my strategy.
A reaction I have had on several occasions from them is to bring up an example of a LIC boasting great performance figures.
Continue reading “SHOULD I INVEST IN ASX LICs VS MANAGED FUNDS?”
Author’s note: In compiling this article I have used data as at 25th April, 2018.
Recently I was checking out Morphic Ethical Equities Fund (MEC) and observed how fickle the premium / discount to NTA can behave. It is almost one year since listing and this type of pattern I see quite often in new LICs. Continue reading “Investing in global LICs at IPO stage & brief thoughts on WAM Global.”